Literature DB >> 12054096

Antidepressants in pain management.

Gregory T Carter1, Mark D Sullivan.   

Abstract

Antidepressants exhibit a number of pharmacological mechanisms, including norepinephrine and serotonin modulation, direct and indirect effects on opioid receptors, inhibition of histamine, cholinergic and N-methyl-D-aspartate receptors, and inhibition of ion channel activity. Although it is not entirely clear which mechanisms produce analgesia and to what extent, the available animal and clinical trials data indicates that tricyclic antidepressants are effective in treating many types of pain. The newer selective serotonin reuptake inhibitors also appear to be effective for chronic headache and other non-neuropathic forms of chronic pain but are not as well studied. This article reviews the current basic and clinical research on antidepressants in pain management.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054096

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  8 in total

1.  Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.

Authors:  Piotr Popik; Martyna Krawczyk; Krystyna Golembiowska; Gabriel Nowak; Aaron Janowsky; Phil Skolnick; Arnold Lippa; Anthony S Basile
Journal:  Cell Mol Neurobiol       Date:  2006-04-25       Impact factor: 5.046

2.  A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

Authors:  F S Hall; J M Schwarzbaum; M T G Perona; J S Templin; M G Caron; K-P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

3.  Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.

Authors:  Marc Afilalo; Mila S Etropolski; Brigitte Kuperwasser; Kathy Kelly; Akiko Okamoto; Ilse Van Hove; Achim Steup; Bernd Lange; Christine Rauschkolb; Juergen Haeussler
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats.

Authors:  Shuxing Wang; Lin Zhang; Grewo Lim; Backil Sung; Yinghong Tian; Chiu-Wen Chou; Hayley Hernstadt; Gabriel Rusanescu; Yuxin Ma; Jianren Mao
Journal:  Brain Res       Date:  2009-07-09       Impact factor: 3.252

5.  Exacerbated mechanical allodynia in rats with depression-like behavior.

Authors:  Qing Zeng; Shuxing Wang; Grewo Lim; Liling Yang; Ji Mao; Backil Sung; Yang Chang; Jeong-Ae Lim; Gongshe Guo; Jianren Mao
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

Review 6.  The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol.

Authors:  Thomas M Tzschentke; Thomas Christoph; Babette Y Kögel
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

7.  Increased affective bias revealed using experimental graded heat stimuli in young depressed adults: evidence of "emotional allodynia".

Authors:  Irina A Strigo; Alan N Simmons; Scott C Matthews; Arthur D Bud Craig; Martin P Paulus
Journal:  Psychosom Med       Date:  2008-03-31       Impact factor: 4.312

Review 8.  Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?

Authors:  Oliver Knapp; Jeffrey R McArthur; David J Adams
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.